Laptops are the crux of any portable setup, but if you're a remote worker or on the move, the right accessories can improve ...
Most of the Android launchers I've ever heard about or tested are designed for function. Microsoft Launcher is great for ...
It’s been 45 days since the Neo went on sale at $599. In that time, Apple has had no problem making the case that the ...
Some of these are staples: Readwise Reader, Pocket Casts, MyMind, and Arc are all apps I’ve used for a long time and am very ...
One of the nice things about magnetic storage is that as long as the magnetic layer remains intact, the data it contains ...
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...
UB and Roswell Park researchers created MIRACLE, an AI tool that combines clinical data, CT imaging and LLM insights to ...
Corporate investment in AI continues to accelerate globally and patent filings for AI-related inventions are rising across ...
Data from Abnormal AI shows why AI-driven behavioral baselining is now the only way to catch "perfect" impersonation.
In a significant development for diabetes treatment, Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) for its generic version of dapagliflozin tablets, ...
“Claim 14 does not contain an inventive concept sufficient to transform this abstract idea into a patent-eligible application.” – Federal Circuit McFadden, who represented himself pro se, filed patent ...
Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results